Immunogenicity of a whole-cell pertussis vaccine with low lipopolysaccharide content in Infants

Clinical and Vaccine Immunology

Volumn 16, Issue 4, 2009, Pages 544-550

  Zorzeto, Tatiane Queiroz ^a   Higashi, Hisako Gondo ^b   Silva, Marcos Tadeu Nolasco Da ^a   De Carniel, Emilia Faria ^a   Dias, Waldely Oliveira ^b   Ramalho, Vanessa Domingues ^a   Mazzola, Taís Nitsch ^a   Lima, Simone Corte Batista Souza ^a   Morcillo, Andre Moreno ^a   Stephano, Marco Antonio ^c   De Antonio, Maria Ângela Reis Goes ^a   De Zanolli, Maria Lurdes ^a   Raw, Isaias ^a   Vilela, Maria Marluce Dos Santos ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 4; PERTUSSIS VACCINE; PERTUSSIS VACCINE WITH LIPOPOLYSACCHARIDE CONTENT; PHYTOHEMAGGLUTININ; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; BORDETELLA PERTUSSIS; CD3+ T LYMPHOCYTE; CELL EXPANSION; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GEOMETRY; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; INFANT; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERTUSSIS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

ANTITOXINS; BORDETELLA PERTUSSIS; CELL PROLIFERATION; CYTOKINES; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; INFANT; LIPOPOLYSACCHARIDES; MALE; PERTUSSIS VACCINE; T-LYMPHOCYTE SUBSETS;

EID: 64549141964     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00339-08     Document Type: Article

References (48)

1. Adkins, B., C. Leclerc, and S. Marshall-Clarke. 2004. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4:553-564.
2. Armstrong, M. E., C. E. Loscher, M. A. Lynch, and K H. G. Mills. 2003. IL-1β-dependent neurological effects of the whole cell pertussis vaccine: a role for IL-1-associated signalling components in vaccine reactogenicity. J. Neuroimmunol. 136:25-33.
3. Ausiello, C. M., R. Lande, A. La Sala, F. Urbani, and A. Cassone. 1998. Cell-mediated immune response of healthy adults to Bordetella pertussis vaccine antigens. J. Infect. Dis. 178:466-470.
4. Ausiello, C. M., R. Lande, P. Stefanelli, C. Fazio, G. Fedele, R. Palazzo, F. Urbani, and P. Mastrantonio. 2003. T-cell immune response assessment as complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice. Clin. Diagn. Lab. Immunol. 10:637-642.
5. Ausiello, C. M., R. Lande, F. Urbani, B. Di Carlo, P. Stefanelli, S. Salmaso, P. Mastrantonio, and A. Cassone. 2000. Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine. J. Infect. Dis. 181:1989-1995.
6. Ausiello, C. M., F. Urbani, A. La Sala, R. Lande, and A. Cassone. 1997. Vaccine-and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect. Immun. 65:2168-2174.
7. Ausiello, C. M., F. Urbani, A. La Sala, R. Lande, A. Piscitelli, and A. Cassone. 1997. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis. Dev. Biol. Stand. 89:315-320.
8. Baker, J. P., and S. L. Katz. 2004. Childhood vaccine development: an overview. Pediatr. Res. 55:347-356.
9. Bertotto, A., F. M. De Benedictis, C. Vagliasindi, M. Radicioni, F. Spinozzi, G. M. Fabietti, G. Castelluci, L. Ferraro, R. Cozzali, A. Niccoli, and R. Vaccaro. 1997. Gamma delta T cells are decreased in the blood of children with Bordetella pertussis infection. Acta Paediatr. 86:114-115.
10. Blackwelder, W. C. 1995. Similarity/equivalence trials for combination vaccines. Ann. N. Y. Acad. Sci. 754:321-328.
11. Born, W., C. Miles, J. White, R. O'Brien, J. H. Freed, P. Marrack, J. Kappler, and R. T. Kubo. 1987. Peptide sequences of T-cell receptor γ and δ chains are identical to predicted X and γ proteins. Nature 330:572-574.
12. Brenner, M. B., J. McLean, D. P. Dialynas, J. L. Strominger, F. L. Owen, J. G. Seidman, S. Ip, F. Rosen, and M. S. Krangel. 1986. Identification of a putative second T-cell receptor. Nature 322:145-149.
13. Byrne, P., P. McGuirk, S. Todryk, and K. H. Mills. 2004. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells. Eur. J. Immunol. 34:2579-2588.
14. Cassone, A., C. M. Ausiello, F. Urbani, R. Lande, M. Giuliano, A. La Sala, A. Piscitelli, and S. Salmaso. 1997. Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. Arch. Pediatr. Adolesc. Med. 151:283-289.
15. Chien, Y. H., M. Iwashima, K. Kaplan, J. F. Elliott, and M. M. Davis. 1987. A new T-cell receptor gene located within the alpha locus and expressed early in T-cell differentiation. Nature 327:677-682.
16. Del Giudice, G. 2003. Vaccination strategies: an overview. Vaccine 21:S83-S88.
17. Edwards, K. M., and M. D. Decker. 2004. Pertussis vaccine, p. 471-528. In S. Plotkin and W. A. Orenstein (ed.), Vaccines, 4th ed. W. A. Saunders, Philadelphia, PA.
18. Forsyth, K. D., C.-H. Wirsing von Konig, T. Tan, J. Caro, and S. Plotkin. 2007. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 25:2634-2642.
19. Fletcher, M. A., P. Saliou, C. Ethevenaux, and S. A. Plotkin. 2001. The efficacy of whole cell pertussis immunization: collected data on a vaccine produced in France. Public Health 115:119-129.
20. Gaines, M. H., and G. Biberfeld. 2000. Measurement of lymphoproliferation at the single-cell level by flow cytometry. Methods Mol. Biol. 134:243-255.
21. Greco, D., S. Salmaso, P. Mastrantonio, M. Giuliano, A. E. Tozzi, A. Anemona, M. L. Ciofi degli Atti, A. Giammanco, P. Panei, W. C. Black-welder, D. L. Klein, S. G. Wassilak, et al. 1996. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N. Engl. J. Med. 334:341-348.
22. Gustafsson, L., H. O. Hallander, P. Olin, E. Reizenstein, and J. Storsaeter. 1996. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med. 334:349-355.
23. Hayday, A. C. 2000. 78 cells: a right time and a right place for a conserved third way of protection. Annu. Rev. Immunol. 18:975-1026.
24. Higgins, S. C., A. G. Jarnicki, E. C. Lavelle, and K. H. Mills. 2006. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis:role of IL-17-producing T cells. J. Immunol. 177:7980-7989.
25. Horne, A. D. 1995. The statistical analysis of immunogenicity data in vaccine trials. Ann. N. Y. Acad. Sci. 754:329-346.
26. King, D. P., D. M. Hyde, K. A. Jackson, D. M. Novosad, T. N. Ellis, L. Putney, M. Y. Stovall, L. S. Van Winkle, B. L. Beaman, and D. A. Ferrick. 1999. Protective response to pulmonary injury requires 78 T lymphocytes. J. Immunol. 162:5033-5036.
27. Leef, M., K. L. Elkins, J. Barbic, and R. D. Shahin. 2000. Protective immunity to Bordetella pertussis requires both B cells and CD4 T cells for key functions other than specific antibody production. J. Exp. Med. 191:1841-1852.
28. Loscher, C. E., S. Donnely, S. McBennett, M. A. Lynch, and K. H. G. Mills. 1998. Proinflammatory cytokines in the adverse systemic and neurologic effects associated with parenteral injection of a whole cell pertussis vaccine. Ann. N. Y. Acad. Sci. 856:274-277.
29. Mahon, B. P., M. S. Ryan, F. Griffin, and K. H. Mills. 1996. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Infect. Immun. 64:5295-5301.
30. Mascart, F., V. Verscheure, A. Malfroot, M. Hainaut, D. Pierard, S. Temer-man, A. Peltier, A. S. Debrie, J. Levy, G. Del Giudice, and C. Locht. 2003.Bordetella pertussis infection in 1-month-old infants promotes type 1 T cell responses. J. Immunol. 170:1504-1509.
31. Mazzola, T. N., M. T. Da Silva, Y. M. Moreno, S. C. Lima, E. F. Carniel, A. M. Morcillo, M. A. Antonio, M. L. Zanolli, A. A. Netto, M. H. Blotta, I. Raw, and M. M. Vilela. 2007. Robust 78 T cell expansion in infants immunized at birth with BCG vaccine. Vaccine 25:6313-6320.
32. Meade, B. D., A. Deforest, K. M. Edwards, T. A. Romani, F. Lynn, C. H. O'Brien, C. B. Swartz, G. F. Reed, and M. A. Deloria. 1995. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics 96:570-575.
33. Mills, K. H., M. Ryan, E. Ryan, and B. P. Mahon. 1998. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect. Immun. 66:594-602.
34. Mills, K. H. 2001. Immunity to Bordetella pertussis. Microbes Infect. 3:655-677.
35. O'Neill, L. A. J. 2006. How Toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18:3-9.
36. Rohmel, J. 1998. Therapeutic equivalence investigations: statistical considerations. Stat. Med. 17:1703-1714.
37. Ryan, M., G. Murphy, I. Gothefors, I. Nilsson, J. Storsaeter, and K. H. Mills. 1997. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J. Infect. Dis. 175:1246-1250.
38. Ryan, M., G. Murphy, E. Ryan, I. Nilsson, F. Shackley, I. Gothefors, K. Oymar, E. Miller, J. Storsaeter, and K. H. Mills. 1998. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 93:1-10.
39. Saito, H., D. M. Kranz, Y. Takagaki, A. Hayday, H. Elsen, and S. Tonegawa. 1984. Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequences. Nature 309:757-762.
40. Skeen, M. J., E. P. Rix, M. M. Freeman, and H. K. Ziegler. 2001. Exaggerated proinflammatory and Th1 responses in the absence of γδ T cells after infection with Listeria monocytogenes. Infect. Immun. 69:7213-7223.
41. Sonobe, M. H., A. G. Trezena, F. B. Guilhen, V. L. Takano, F. Fratelli, D. Sakauchi, J. F. Morais, S. M. A. Prado, and H. K. Higashi. 2007. Determination of low tetanus or diphtheria antitoxin titers in sera by a toxin neutralization assay and a modified toxin-binding inhibition test. Braz. J. Med. Biol. Res. 40:69-76.
42. Spada, F. M., E. P. Grant, P. J. Peters, M. Sugita, A. Melián, D. S. Leslie, H. K. Lee, E. van Donselaar, D. A. Hanson, A. M. Krensky, O. Majdic, S. A. Porcelli, C. T. Morita, and M. B. Brenner. 2000. Self-recognition of CD1 by γδ T cells: implications for innate immunity. J. Exp. Med. 191:937-948.
43. Stehr, K., J. D. Cherry, U. Heininger, S. Schmitt-Grohé, M. Uberall, S. Laussucq, T. Eckhardt, M. Meyer, R. Engelhardt, and P. Christenson. 1998. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DtaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics 101: 1-11.
44. Tan, T., E. Trindade, and D. Skowronski. 2005. Epidemiology of pertussis. Pediatr. Infect. Dis. J. 24:S10-S18.
45. Wirsing von König, C. H., M. Campins-Marti, A. Finn, N. Guiso, J. Mertsola, and J. Liese. 2005. Pertussis immunization in the global pertussis initiative European region: recommended strategies and implementation considerations. Pediatr. Infect. Dis. J. 24:S87-S92.
46. World Health Organization. 2004. Prevention and care of illness. Neonates and infants newborn health and survival. A call to action. World Health Organization, Geneva, Switzerland.
47. World Health Organization. 1999. Pertussis vaccines: WHO position papers. Wkly. Epidemiol. Rec. 18:137-144.
48. Zachariadis, O., J. P. Cassidy, J. Brady, and B. P. Mahon. 2006. Bordetella pertussis infection in the murine respiratory tract. Infect. Immun. 74:1837-1845.